Free trial units of all ARISTADA® (aripiprazole lauroxil) doses, including the first and only 2-month (1064-mg) LAI option for schizophrenia, are available for hospitalized patients
Pharmacies of registered hospitals can order free trial units of ARISTADA, and orders ship directly to the inpatient hospital.* Hospitalized patients with schizophrenia may receive up to 2 free trial units of ARISTADA per calendar year, subject to quantity limits. There is no requirement for subsequent use of ARISTADA for any patient receiving a free trial unit through this program.
*Shipments will not be processed on holidays or pending inclement weather. These factors may result in a delay in shipment.
Additional limits may apply per institution. This program, as amended from time to time, will be available through December 31, 2019.†
†Alkermes, Inc. may terminate the program prior to December 31, 2019, upon 60 days’ notice to all participating inpatient pharmacies, or upon less or no notice if there is a change in interpretation of federal or state laws supporting the continuation of this program.
For patients transitioning from hospital to outpatient care, be sure to select the Transition of Care Support Program on the enrollment form. A prescription is not required for transition support. Through the program, ARISTADA Care Support nurse coordinators can: